A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GB1211 in Healthy Subjects and in Subjects With Suspected Non-Alcoholic Steato-Hepatitis (NASH) and Liver Fibrosis
Condition: Safety and Tolerability Interventions: Drug: GB1211; Drug: Placebo Sponsor: Galecto Biotech AB Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials